IN Brief:
- IQE will supply six-inch gallium arsenide epiwafers for Quintessent's quantum-dot laser technology.
- The agreement supports customer sampling as Quintessent works towards commercial deployment and new product introductions.
- IQE and Quintessent have worked together for more than a decade on scaling quantum-dot laser epitaxy.
Six-inch gallium arsenide epiwafers from IQE will support Quintessent’s quantum-dot laser customer-sampling programme under a new purchase agreement between the two companies.
The agreement extends a relationship of more than a decade and follows an initial strategic announcement and purchase order in January 2025. IQE will provide the material through its foundry-ready service as Quintessent progresses its laser architecture towards commercial deployment and new product introductions.
Epitaxy sits close to the performance limits of a semiconductor laser because the composition, thickness, interfaces, and uniformity of the deposited semiconductor layers shape much of the finished device’s optical behaviour before wafer fabrication proceeds.
Scaling a new laser architecture therefore requires more than demonstrating a high-performing individual device. The material process has to deliver comparable results across a larger wafer, between wafers, and across successive production lots.
Quintessent uses gallium arsenide quantum-dot gain material for optical-interconnect applications. Quantum dots confine charge carriers within nanoscale regions, altering the gain characteristics of the active material compared with conventional quantum-well structures and giving device designers another route to address efficiency, temperature behaviour, and reliability.
The two companies formalised a larger-scale manufacturing relationship in January 2025, when they announced an epitaxial wafer supply chain covering quantum-dot lasers and semiconductor optical amplifiers. That work also centred on six-inch GaAs material, establishing a route towards larger-scale production than smaller development wafer formats can provide.
Larger wafers improve potential manufacturing economics by allowing more devices to be processed in each cycle, but they also make uniformity harder to maintain. Thickness, composition, defect levels, and other process variables have to remain within specification across a larger area if the additional wafer real estate is to translate into useful yield.
The latest purchase agreement brings that manufacturing work into Quintessent’s customer-sampling phase. The company has already begun providing evaluation hardware around its quantum-dot optical technology, allowing prospective users to measure performance inside their own development environments.
That step exposes the device to a broader range of operating conditions than supplier laboratory testing alone. Customers can assess optical output, wavelength stability, thermal response, coupling, control requirements, and reliability, while the supplier has to demonstrate that subsequent devices remain sufficiently consistent for those results to support qualification.
Existing Quintessent customer-sampling activity has also been supported by a $40 million Series A funding round, with the company working towards reliability qualification, manufacturing expansion, and further optical products.
The IQE supply relationship provides one part of that manufacturing structure. Compound-semiconductor epitaxy requires specialised equipment, materials control, and process knowledge, creating a choice for photonics developers between building substantial internal capacity or qualifying an external wafer supplier.
Using an established epitaxy manufacturer can reduce the amount of infrastructure the device developer needs to own, although it increases the importance of supplier qualification and long-term process control. If the laser progresses into larger production volumes, material consistency becomes part of the customer’s component qualification rather than simply an upstream manufacturing concern.
IQE and Quintessent describe quantum-dot lasers as a route towards lower-power and more reliable optical interconnects for AI data-centre infrastructure. Those remain supplier claims that now have to survive customer evaluation against established laser sources and competing photonic architectures.
The commercial value and volume of the new purchase agreement have not been disclosed. It is therefore a manufacturing and qualification milestone rather than evidence that Quintessent has already entered high-volume commercial production.
Customer sampling is nonetheless a material change from internal device development because equipment is being placed into prospective users’ test environments. The result is a far less forgiving measure of whether the architecture, material supply, and manufacturing process are ready to support a repeatable component.
After more than a decade of collaboration, the next meaningful evidence will come from qualification results and follow-on wafer orders. Quantum-dot laser performance may attract the initial attention, but six-inch epitaxy will have to make that performance repeatable enough for customers to design around it.
